RecruitingNCT06940414

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in a Community-Based Primary Care Setting

Sponsor

Xiujuan Zang

Enrollment

1,890 participants

Start Date

Apr 28, 2025

Study Type

OBSERVATIONAL

Conditions

Chronic Kidney Disease(CKD)Hyperkalemia

Summary

The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are: 1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters. Participants will: 1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information. The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is measuring how common high potassium levels (hyperkalemia) are in people with chronic kidney disease (CKD) who are not on dialysis, and what factors raise the risk. **You may be eligible if...** - You are 18 or older - You have a confirmed diagnosis of chronic kidney disease (CKD) - Your vital signs are stable (normal temperature, pulse, blood pressure, breathing rate) - You are willing to participate and sign the consent form **You may NOT be eligible if...** - You are having an acute cardiovascular event (such as a heart attack or stroke) - You are in the acute phase of a serious diabetes complication - You are in acute kidney injury - You are already on dialysis or kidney replacement therapy - You are pregnant or breastfeeding - You are currently enrolled in another study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention

This is an observational study with no interventions. POCT devices, provided by Eaglenos Sciences, Inc., are used to measure blood glucose, creatinine, uric acid, hemoglobin, and potassium levels in non-dialysis CKD patients for data collection purposes only.

Locations(1)

Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06940414

Related Trials

Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

NCT073701941 location

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

NCT069066276 locations

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

NCT069066406 locations

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

NCT0576683937 locations

Hyperkalemia Quality Improvement Program (HK-QIP) Study

NCT0688426749 locations